VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $18,152,000 | +62.9% | 781,088 | +11.6% | 0.16% | +38.4% |
| Q1 2018 | $11,142,000 | -42.5% | 699,887 | -24.9% | 0.11% | -17.6% |
| Q4 2017 | $19,365,000 | -31.7% | 931,893 | -52.9% | 0.14% | -47.1% |
| Q3 2017 | $28,353,000 | -19.3% | 1,978,555 | -2.6% | 0.26% | -29.6% |
| Q2 2017 | $35,138,000 | +118.7% | 2,031,094 | +39.4% | 0.36% | +95.2% |
| Q1 2017 | $16,065,000 | -4.6% | 1,456,520 | +25.6% | 0.19% | +14.7% |
| Q4 2016 | $16,844,000 | +19.8% | 1,160,056 | +102.6% | 0.16% | +6.5% |
| Q3 2016 | $14,059,000 | +90.1% | 572,655 | +56.0% | 0.15% | +75.9% |
| Q2 2016 | $7,394,000 | -12.7% | 367,153 | +14.0% | 0.09% | -27.5% |
| Q1 2016 | $8,470,000 | -79.8% | 322,067 | -22.1% | 0.12% | -75.9% |
| Q4 2015 | $42,018,000 | +776.5% | 413,358 | +1815.4% | 0.50% | +641.8% |
| Q2 2015 | $4,794,000 | +131.1% | 21,581 | +106.7% | 0.07% | +103.0% |
| Q1 2015 | $2,074,000 | -25.3% | 10,443 | -46.1% | 0.03% | -21.4% |
| Q4 2014 | $2,775,000 | -65.9% | 19,390 | -68.8% | 0.04% | -66.4% |
| Q3 2014 | $8,144,000 | +10.2% | 62,073 | +5.9% | 0.12% | +9.6% |
| Q2 2014 | $7,391,000 | +34.7% | 58,604 | +40.8% | 0.11% | +23.9% |
| Q1 2014 | $5,488,000 | +1676.1% | 41,633 | +1480.6% | 0.09% | +1740.0% |
| Q4 2013 | $309,000 | -92.3% | 2,634 | -94.4% | 0.01% | -94.9% |
| Q2 2013 | $4,028,000 | – | 46,798 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |